Edition:
International

Biotechnology & Medical Research

Page 1

Adhera Therapeutics Signs Letter Of Intent With Melior Pharmaceuticals Ii To Acquire A New Class Of Drug For Parkinson’S Disease

Monday, 7 Jun 2021 08:45am EDT

June 7 (Reuters) - Adhera Therapeutics Inc ::ADHERA THERAPEUTICS SIGNS LETTER OF INTENT WITH MELIOR PHARMACEUTICALS II TO ACQUIRE A NEW CLASS OF DRUG FOR PARKINSON’S DISEASE.

Arocell Announces Takeover Offer For IDL Biotech

Monday, 10 May 2021 02:00am EDT

May 10 (Reuters) - AroCell AB (publ) ::MAKES PUBLIC TAKEOVER OFFER TO SHAREHOLDERS IN IDL BIOTECH AB (PUBL).OFFERS 0.63 AROCELL-SHARES FOR EACH SHARE IN IDL.OFFERS VALUES IDL SHARE AT ABOUT SEK 3.75 AND TOTAL NUMBER OF SHARES IN IDL AT ABOUT SEK 236.8 MILLION.OFFER REPRESENTS PREMIUM OF 56% IN REGARD TO CLOSING PRICE OF SEK 5.96 FOR AROCELL SHARE AND SEK 2.41 FOR IDL SHARE ON MAY 7.SYNERGY SAVINGS ESTIMATED IN TOTAL TO BE OF SEK 8 - 11 MILLION PER YEAR INITIALLY.IN TOTAL, AROCELL SEES DIRECT SAVINGS WITHIN MANUFACTURING AND LOGISTICS OF SEK 2-3 MILLION PER YEAR INITIALLY.ISSUE OF NEW SHARES TO COMPRISE ABOUT 39.7 MILLION SHARES IN CO, CORRESPONDING TO 34.4% OF SHARES POST THE ISSUE.

Athenex To Acquire Kuur Therapeutics To Expand Cell Therapy Development With Off-The-Shelf Engineered Car-Nkt Platform

Tuesday, 4 May 2021 05:04pm EDT

May 4 (Reuters) - Athenex Inc ::ATHENEX TO ACQUIRE KUUR THERAPEUTICS TO EXPAND CELL THERAPY DEVELOPMENT WITH OFF-THE-SHELF ENGINEERED CAR-NKT PLATFORM.ATHENEX INC - DEAL FOR TOTAL POTENTIAL CONSIDERATION OF $185 MILLION.ATHENEX INC - UNDER TERMS OF AGREEMENT, ATHENEX WILL PAY $70 MILLION UPFRONT TO KUUR SHAREHOLDERS AND CERTAIN OF ITS FORMER EMPLOYEES AND DIRECTORS.ATHENEX - TOTAL POTENTIAL CONSIDERATION OF $185 MILLION, COMPRISING $70 MILLION UPFRONT PRIMARILY IN ATHENEX STOCK, & $115 MILLION IN DEVELOPMENT MILESTONES.

Marijuana Co Of America Signs LOI To Acquire cDistro, cDistro.com

Tuesday, 4 May 2021 08:30am EDT

May 4 (Reuters) - Marijuana Company Of America Inc ::MARIJUANA COMPANY OF AMERICA, INC. SIGNS LETTER OF INTENT TO ACQUIRE CDISTRO AND CDISTRO.COM.

Sorrento Enters Into Merger Agreement To Acquire ACEA Therapeutics

Monday, 5 Apr 2021 09:00am EDT

April 5 (Reuters) - Sorrento Therapeutics Inc ::SORRENTO ENTERS INTO MERGER AGREEMENT TO ACQUIRE LATE-STAGE ONCOLOGY COMPANY ACEA THERAPEUTICS.SORRENTO THERAPEUTICS INC - ACQUISITION WILL INCLUDE ABIVERTINIB, AC0058, AC0939, AND ACEA'S EXTENSIVE PROPRIETARY LIBRARY OF SMALL MOLECULES.

Invitae To Acquire Genosity

Monday, 5 Apr 2021 07:30am EDT

April 5 (Reuters) - Invitae Corp ::INVITAE TO ACQUIRE GENOSITY TO ACCELERATE ACCESS TO PERSONALIZED ONCOLOGY TESTING WORLDWIDE.INVITAE CORP - WILL ACQUIRE GENOSITY FOR APPROXIMATELY $200 MILLION.INVITAE CORP - IN CONNECTION WITH TRANSACTION, INVITAE WILL RSUS HAVING A VALUE OF UP TO $15 MILLION TO CERTAIN CONTINUING EMPLOYEES OF GENOSITY.INVITAE CORP - RSUS WILL BE GRANTED UNDER INVITAE'S 2015 STOCK INCENTIVE PLAN.

Northern Data Closes Acquisition Of Data Center Site In Sweden

Monday, 8 Mar 2021 01:30am EST

March 8 (Reuters) - NORTHERN DATA AG ::CLOSES ACQUISITION OF DATA CENTER SITE IN NORTHERN SWEDEN AND CONTINUES SUCCESSFUL EXPANSION DRIVEN BY ENORMOUS DEMAND.

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary